Literature DB >> 29379885

A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity.

Samuel O Adeosun1, Kyle H Moore1, David M Lang1, Assumpta C Nwaneri2, Terry D Hinds2, David E Stec1.   

Abstract

Biliverdin reductase (BVR) is the enzyme responsible for the last step in the production of bilirubin from the breakdown of heme. Bilirubin is one of the most potent antioxidant molecules in the body. Monitoring BVR activity is essential in studying the antioxidant capacity of cells and tissues. Traditional methods of determining BVR activity have relied on the measurement of bilirubin converted from biliverdin using absorbance spectroscopy. The approach has limited sensitivity and requires large quantities of cells or tissues. We have developed a novel fluorescence-based method utilizing the eel protein, UnaG, for the detection of bilirubin produced by BVR. The UnaG protein only fluoresces by the induction of bilirubin. We have also used this approach to measure intracellular bilirubin content of cultured cells. We validated this assay using cell lysates from mouse liver and immortalized murine hepatic cell line (Hepa1c1c7) and kidney cell line (MCT) in which BVR isoform A (BVRA) was either knocked out via CRISPR or stably overexpressed by lentivirus. Also, we tested the method using previously reported putative BVRA inhibitors, Closantel and Ebselen. These studies show a new method for measuring bilirubin intracellularly and in lysates.

Entities:  

Keywords:  Antioxidant; Bilirubin; Heme Oxygenase; Oxidative Stress; UnaG

Year:  2018        PMID: 29379885      PMCID: PMC5785779          DOI: 10.20455/ros.2018.809

Source DB:  PubMed          Journal:  React Oxyg Species (Apex)


  17 in total

Review 1.  Antioxidant activities of bile pigments.

Authors:  Roland Stocker
Journal:  Antioxid Redox Signal       Date:  2004-10       Impact factor: 8.401

2.  Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Terry D Hinds; Katherine A Burns; Peter A Hosick; Lucien McBeth; Andrea Nestor-Kalinoski; Heather A Drummond; Abdulhadi A AlAmodi; Michael W Hankins; John P Vanden Heuvel; David E Stec
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

3.  Detection of biliverdin reductase activity.

Authors:  Tian-Jun Huang
Journal:  Curr Protoc Toxicol       Date:  2002

4.  Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.

Authors:  Terry D Hinds; Peter A Hosick; Shujuan Chen; Robert H Tukey; Michael W Hankins; Andrea Nestor-Kalinoski; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-17       Impact factor: 4.310

5.  High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy.

Authors:  Seung Seok Han; Ki Young Na; Dong-Wan Chae; Yon Su Kim; Suhnggwon Kim; Ho Jun Chin
Journal:  Tohoku J Exp Med       Date:  2010-06       Impact factor: 1.848

6.  Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

Authors:  Charlotte Andersson; Peter Weeke; Emil Loldrup Fosbøl; Bente Brendorp; Lars Køber; Walmir Coutinho; Arya M Sharma; Luc Van Gaal; Nick Finer; W Philip T James; Ian D Caterson; Richard A Rode; Christian Torp-Pedersen
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

Review 7.  Pharmacological and clinical aspects of heme oxygenase.

Authors:  Nader G Abraham; Attallah Kappas
Journal:  Pharmacol Rev       Date:  2008-03-06       Impact factor: 25.468

8.  Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.

Authors:  Terry D Hinds; Komal Sodhi; Charles Meadows; Larisa Fedorova; Nitin Puri; Dong Hyun Kim; Stephen J Peterson; Joseph Shapiro; Nader G Abraham; Attallah Kappas
Journal:  Obesity (Silver Spring)       Date:  2013-12-02       Impact factor: 5.002

9.  Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis.

Authors:  T P Haverty; C J Kelly; W H Hines; P S Amenta; M Watanabe; R A Harper; N A Kefalides; E G Neilson
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

10.  Bilirubin Binding to PPARα Inhibits Lipid Accumulation.

Authors:  David E Stec; Kezia John; Christopher J Trabbic; Amarjit Luniwal; Michael W Hankins; Justin Baum; Terry D Hinds
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more
  12 in total

1.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

2.  RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubin.

Authors:  Darren M Gordon; Thomas M Blomquist; Scott A Miruzzi; Robert McCullumsmith; David E Stec; Terry D Hinds
Journal:  Physiol Genomics       Date:  2019-05-10       Impact factor: 3.107

Review 3.  Novel Function for Bilirubin as a Metabolic Signaling Molecule: Implications for Kidney Diseases.

Authors:  David E Stec; Claudio Tiribelli; Olufunto O Badmus; Terry D Hinds
Journal:  Kidney360       Date:  2022-03-25

4.  Disrupting Fluorescence by Mutagenesis in a Green Fluorescent Fatty Acid Binding Protein from a Marine Eel.

Authors:  Sara Rose Krivoshik; Andrew M Guarnaccia; Daniel B Fried; David F Gruber; Jean P Gaffney
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

5.  Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells.

Authors:  Samuel O Adeosun; Darren M Gordon; Mary Frances Weeks; Kyle H Moore; John E Hall; Terry D Hinds; David E Stec
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-04

Review 6.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

7.  Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice.

Authors:  David E Stec; Darren M Gordon; Andrea L Nestor-Kalinoski; Matthew C Donald; Zachary L Mitchell; Justin F Creeden; Terry D Hinds
Journal:  Biomolecules       Date:  2020-03-02

8.  Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK-SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue.

Authors:  Terry D Hinds; Zachary A Kipp; Mei Xu; Frederique B Yiannikouris; Andrew J Morris; Donald F Stec; Walter Wahli; David E Stec
Journal:  Cells       Date:  2021-12-21       Impact factor: 6.600

9.  Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1.

Authors:  Terry D Hinds; Justin F Creeden; Darren M Gordon; Adam C Spegele; Steven L Britton; Lauren G Koch; David E Stec
Journal:  Antioxidants (Basel)       Date:  2020-09-19

10.  Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha).

Authors:  Darren M Gordon; Stephen H Hong; Zachary A Kipp; Terry D Hinds
Journal:  Molecules       Date:  2021-05-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.